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Summary 
CC chemokines constitute a novel class of cytokines that attract and activate monocytes and 
lymphocytes, as well as basophil and eosinophil lenkocytes, with distinct target cell profiles, and 
are believed to be involved in the regulation of different types of inflammation. The action of 
the recently identified monocyte chemotactic protein 3 (MCP-3) on human basophil and eosinophil 
function was studied and compared with that of other CC chemokines. In basophils,  MCP-3, 
MCP-1, P.ANTES, and macrophage inflammatory protein (MIP)-loe all induced cyrosolic-frce 
calcium concentration ([Ca  2  +  ]i) changes and, with different efticacies, chemotaxis (R_ANTES -- 
MCP-3 >> MCP-1 >  MIP-lc~),  histamine release (MCP-1  =  MCP-3 >> P.ANTES >  MIP- 
lc  0' and leukotriene C4 formation, after IL-3 pretreatment (MCP-1  =  MCP-3 >> RANTES > 
MIP-loe). Thus, MCP-3 was as effective as MCP-1 as an inducer of mediator release, and as 
effective as R.ANTES as a stimulus of basophil migration. In contrast to MCP-1, MCP-3 was 
also a stimulus for eosinophils, and induced [Ca2+]i changes and chemotaxis as effectively as 
R.ANTES, which is the most potent chemotactic cytokine for these cells. Desensitization of 
the transient changes in [Ca2+]i was used tO assess receptor usage. In basophils, stimulation with 
MCP-3 prevented responsiveness to MCP-1 and R.ANTES, but not to MIP-loe. No single CC 
chemokine (except for MCP-3 itse~ affected the response to MCP-3, however, which was prevented 
only when the cells were prestimulated with both MCP-1 and R.ANTES. In eosinophils, by 
contrast, cross-desensitization  between R.ANTES and MCP-3 was obtained. P.ANTES and to 
a lesser extent MCP-3 also desensitized eosinophils toward MIP-lce. The desensitization data 
suggest the existence of three chemokine receptors: (a) a MCP-1 receptor expressed on basophils 
but not eosinophils that is activated by MCP-1 and MCP-3; (b) a RANTES receptor in basophils 
and eosinophils that is activated by R.ANTES and MCP-3; and (c) a MIP-lce receptor that is 
activated by MIP-loe, R.ANTES and, more weakly, by MCP-3. This study shows that MCP-3 
combines the properties of R.ANTES, a powerful chemoattractant, and MCP-1, a highly effective 
stimulus of mediator release, and thus has a particularly broad range of activities  toward both 
human basophil and eosinophil lenkocytes. 
A  few years  ago,  chemotactic cyt0kines (now termed 
chemokines) were viewed as attractants for neutrophils 
(CXC chemokines) or mononuclear cells (CC chemokines). 
It was then found that IL-8 induces histamine and lenkotriene 
(LT)tC,4 release from IL-3-primed human blood basophils (1, 
2) via GTP-binding protein-coupled receptors (3). Later studies 
showed that some CC chemokines activate basophil as well 
as eosinophil lenkocytes, suggesting that they may function 
1Abbra,  iations used in this paper: [Ca2+]i, cytosolic-free calcium concen- 
tration;  LT, leukotriene;  MCP,  monocyte  chemotactic protein;  MIP, 
macrophage inflammatory protein. 
as mediators in allergic conditions and parasitic infestations. 
Several laboratories reported recently that monocyte chemo- 
tactic protein (MCP)-I is a powerful stimulus of histamine 
release from human blood basophils (4-6).  Priming of the 
ceUs with IL-3, IL-5,  or GM-CSF enhanced histamine re- 
lease and conditioned the cells to produce peptido-lenkotrienes 
in response to MCP-1, which was considerably more potent 
and effective than IL-8 (4, 6). Significant but less pronounced 
release was observed in primed basophils upon stimulation 
with RANTES and macrophage inflammatory protein (MIP)- 
lot (7-9). A direct comparison recently confirmed that MCP-1 
is superior to R.ANTES as a stimulus of histamine and LTC4 
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tent than MCP-1 as a basophil chemoattractant (9). R.ANTES 
and MIP-loe are also potent chemoattractants for eosinophil 
leukocytes, while MCP-1 is totally inactive on these ceils (10). 
A novel CC chemokine was recently identified in the su- 
pernatants  of osteosarcoma call cultures  (11), and  termed 
MCP-3 because of its marked sequence similarity with MCP-1. 
The cDNA coding for this chemokine was cloned and ex- 
pressed (12, 13). We have now studied the effects of recom- 
binant MCP-3 on human basophil and eosinophil leukocytes 
in comparison with MCP-1, tLANTES, and MIP-lcx. Our 
results show that MCP-3 stimulates both types of leukocytes, 
inducing cytosolic-free calcium changes, chemotaxis, and re- 
lease of histamine  and LTC4. As highly effective chemoat- 
tractant  and inducer of mediator release,  MCP-3 combines 
the properties of MCP-1 and ILANTES, and thus represents 
a most effective chemokine for basophil and eosinophil leu- 
kocytes. 
Materials  and Methods 
Reagents.  Dextran  and  FicoU-Hypaque were obtained  from 
Pharmacia Fine Chemicals (Uppsala, Sweden); EDTA and fura- 
2/AM were from Fhh AG (Buchs, Switzerland); Hepes was from 
Calbiochem-Behring  Corp.  (La Jolla, CA); BSA (fatty acid free) 
was from Boehringer  (Mannheim,  FR.G); ionomycin was from 
Sigma Chemical Co. (St. Louis, MO). All other chemicals were 
of highest  purity available. 
Cytokines.  Recombinant human MCP-1, ILANTES, MIP-loe, 
and MIP-I~ were purchased from Prepro Tech Inc. (Rocky Hill, 
NJ) and MCP-3 was prepared as described by Minty et al. (12). 
Recombinant human IL-3 and IL-8 were kindly provided by Sandoz 
Ltd. (Basal, Switzerland and Vienna, Austria). All proteins were 
dissolved in 20 mM Hepes buffer, pH 7.4, containing  1 mg/ml 
BSA at  10  -s M, and stored at  -70~ 
Cells.  Basophil and eosinophil leukocytes were prepared from 
freshly drawn venous blood of unselected healthy volunteers as de- 
scribed previously (6, 9). Basophlls were purified by centrifugation 
on a discontinuous Percoll gradient followed by negative selection 
with magnetic beads coated with mAbs against CD3, CD4, CDS, 
CD14,  CD16, and CD19 (9). The final preparation consisted of 
80-95% basophils and 5-20% small lymphocytes, and the recovery 
was 30-60%. Eosinophils were purified to 99.5% by combining 
Percoll density gradient centrifugation  and negative selection with 
anti-CD16  mAb-conjugated  immunomagnetic  beads (10). 
Histamine and LTC4 Release.  Basophils  (80-180  x  10Vml) in 
20 mM Hepes, pH 7.4, containing  125 mM NaC1, 5 mM KC1, 
1 mM MgClz, 1 mM CaC12, 0.5 mM glucose, and 0.025%  BSA 
were warmed to 37~  exposed to Ib3 (10 ng/ml) or vehicle for 
10 min, and then challenged with a chemokine. After 20 min, the 
tubes were placed in ice, and histamine and LTC4 were measured 
in the cell supernatant  (14). Histamine  release was expressed in 
percent of the total content of the sample (determined after call 
lysis). LTC4 generation  was expressed as picograms LTC4/D4/E4 
per  nanogram  total  histamine  (which  corresponds  to  "~1,000 
basophiJs). 
Chemotaxi~  Chemotactic chambers with 48-well (Neuro Probe, 
Cabin John,  MD) and polyvinyl-Fyrrolidone-free polycarbonate 
filters with 5-/~m pores (Nucleopore, Pleasanton, CA) were used 
and the assays performed as described previously (9, 10). After in- 
cubation at 37~  in 5% COz for 60 min the filter was removed, 
washed, fixed, and stained, and the migrated cells were counted 
in five randomly  sdected fields of 0.03 mm z. 
Cytosolic-free  Cakium ~[Ca2+].~  Changes.  Purified  eosinophils or 
basophils were loaded with fura-2/AM (0.3 nmol/106 cells) in 20 
mM Hepes, pH 7.4, containing 125 mM NaCI, 5 mM KCI, I mM 
MgC12, 1 mM CaClz, 0.5 mM glucose, and 0.025%  BSA for 30 
rain at 370C, and [Ca2+]i changes were determined after chemo- 
kine  stimulation  (9). In all experiments,  stimulation  with  CC 
chemokines was followed by Ib8 and C5a as controls that showed 
preserved responsiveness of the cells to these two agonists. After 
each  measurement  maximum  and  minimum  fluorescence was 
calibrated by addition  of 5 /zM ionomycin followed by 1 mM 
MnC12. 
Results 
Activation of  Basophils and Eosinophils.  All four chemokines 
tested induced the migration of human blood basophils. As 
shown in Fig. 1 A, MCP-3 and ILANTES were highly effec- 
tive and almost equally potent. Significant, but considerably 
weaker migration was observed with MCP-1 and MIP-lo~. 
Of the four active chemokines, MIP-lo~ had the lowest efficacy, 
while its homologue MIP-I~ was inactive as shown previ- 
ously (9). MCP-1 and MCP-3 also induced a marked, con- 
centration-dependent release of histamine by cells that were 
not primed with IL-3 or another mydoid growth factor.  In 
cells from unsdected donors, as used in this study, RANTES 
showed only borderline effects and MIP-lcx was inactive (Fig. 
1 B). Exocytosis was very rapid and virtually complete within 
1 rain after stimulation with MCP-3 or the other chemokines. 
No CC chemokine induced the generation of LTC4 in un- 
primed cells. 
Priming with IL-3 expectedly enhanced the sensitivity of 
the cells as shown by a shift to the left of the concentration 
dependence curve, the higher amounts of histamine released, 
and the production  of LTC4 (Fig.  2).  MCP-1  and MCP-3 
were about equally active and considerably more effective than 
P.ANTES and MIP-lcx, which induced only low levels of 
release of either product. Since IL-3-primed basophils are par- 
ticularly sensitive to stimulation,  MIP-1/3 was also tested, 
but no activity was found (Fig.  2). 
MCP-3, KANTES, and MIP-lol induced chemotaxis and 
a  rise in  cytosolic-free calcium  concentration  ([Ca2+]i) in 
human eosinophils,  while MCP-1 was completely inactive 
(Fig. 3). Although tLANTES and MIP-lol were chemotactic 
at lower concentrations,  MCP-3  showed high e~cacy and 
induced the migration of similar numbers of ceils as tLANTES. 
The maximal chemotactic index obtained for eosinophils and 
basophils after stimulation with either MCP-3 and R.ANTES 
was well above 20 in all experiments performed.  As previ- 
ously shown for P_ANTES (10), the migration of basophils 
and eosinophils  towards MCP-3 was due to a chemotactic 
rather than chemokinetic effect, since there was little migra- 
tion when the chemokine was placed on both sides of the 
filter  (data  not  shown).  The  activities  of R.ANTES  and 
MIP-lo~ are in agreement with former observations (10), but 
the high  effectiveness of MCP-3 was surprising  since this 
chemokine  shares  "~70%  sequence identity with  MCP-1, 
which does not  stimulate eosinophils. 
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Figure 1.  Basophil  activation  by MCP-3 and related CC chemokines. 
(A) Chemotaxis  in vitro. Each point represents the chemotactic  index  for 
the mean migration  value from two experiments performed  in triplicate 
with basophils  from  different  unselected  donors. MCI~-I  and MIP-I~  were 
tested at three concentrations  only, within the optimal range established 
previously  (9). (B) Histamine  release  from  unprimed  basophils in 20 rain. 
Each point r~ts  the mean  value  from three experiments performed 
in duplicate with basophils from different  unselected  donors. No LTC4 
release was observed under these conditions. MCP-3 (1"3); MCP-1 (O); 
RANTES ((~); and MIP-lo~ (A). 
Figure 3.  Eosinophil  activation  by MCP-3 and related  CC chemokines. 
(,4) Chemotaxis  in vitro. Each  point represents the chemotactic  index  for 
the mean migration  value from two experiments performed  in triplicate 
with eosinophils  from different  unselected  donors. Similar results were 
obtained in three additional  experiments. (B) [Ca2+]i changes (assessed 
as fiJra-2 saturation)  in percent of maximum  rise obtained after stimula- 
tion with RANTES. Mean  values  from  three  experiments  performed  with 
eosinophils from different  unseleeted  donors. MCP-3 (I-3); MCP-1 (O); 
KANTES ((>); and MIP-lcx (A). 
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Figure 2.  Histamine  and L'I~ release  by I~3-Frimed  human  basophils 
after  stimulation  with MCP-3 and related  CC chemokines.  The cells  were 
pretreated for 10 rain with 10 ng/ml 11,3, stimulated  with chemokines, 
and the release of histamine (,4) and LTC4 (B) was determined  after 20 
rain. Mean  values  from  three  experiments  performed  with basophils from 
different unselected  donors. MCP-3 (I-1); MCP-1 (O); RANTES (<)); 
MIP-loL (A); and MIP-1/~ (x). 
Rec~tors.  Earlier studies had suggested that basophil and 
eosinophil leukocytes bear different types of CC chemokine 
receptors  (9,  10). Desensitization experiments were, there- 
fore, performed to gain information on the types of receptors 
involved in the activation by MCP-3. To compare basophil 
and eosinophil responses, [Ca  2  +  ]i changes were used to assess 
receptor activation. 
As shown in Fig. 4,  stimulation with MCP-3 abrogated 
the response of basophils to a subsequent stimulation with 
either R.ANTES or MCP-1.  The [Ca2+]i rise  induced by 
MCP-3, by contrast, was not affected by prior stimulation 
with MCP-1, R.ANTES, or MIP-la (data for MIP-loe not 
shown). The effect of sequential additions of several chemo- 
kines was then studied. As shown in Fig. 5, the [Ca  2  +  ]i rise 
induced by MCP-3 was prevented only when the cells were 
first stimulated with the combination of  MCP-1 and RANTES 
(Fig. 5 A). Prestimulation with MCP-1 and MIP-loz or with 
MIP-Iot and RANTES did not abolish the MCP-3 response. 
The effects as described were independent of the order of ad- 
dition of the two chemokines before MCP-3, and in all cases, 
basophils  remained  responsive  to  IL-8,  indicating  that 
[Ca2+]i changes could still be induced by stimulation via 
CXC chemokine receptors. 
Together,  the results of these experiments indicate that 
MCP-3 acts on basophils via two receptors,  one with selec- 
tivity for MCP-1, and the other with selectivity for RANTES. 
The cells remained responsive  to MCP-3 when only one of 
the receptors  was desensitized (prestimulation with MCP-1 
or RANTES), but became unresponsive when desensitization 
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Figure  4.  Cross-desensitization of basophils stimulated with MCP-3, 
MCP-1, and RANTES. Pura-2-1oaded cells (10~/ml) were sequentially 
stimulated  with 50 nM chemokine  at 90-s intervals, and the [Ca2+]i  - 
dependent  fluorescence  changes  were  recorded.  All stimulus  sequences  were 
tested at least three times with cells from different uuselected donors. 
affected both (prestimulation with MCP-1 and RANTES). 
The finding that stimulation with MCP-3 prevented basophil 
responses to either MCP-1 or RANTES (Fig.  4), but not 
to MIP-lol (Fig. 5 D) suggests the presence of a third receptor 
with sdectivity for MIP-lcx. The desensitization patterns in- 
dicate that the situation is somewhat different for ensinophils. 
It was known from a former study that these cells do not 
respond to MCP-1 (10), and in fact, we observed no [CaZ+]i 
changes and a subsequent challenge with MCP-3 was not 
affected when eosinophils were exposed to MCP-1 (data not 
shown). If eosinophils lack a receptor for MCP-1, the action 
of MCP-3  could be mediated by the RANTES  receptor, 
in which  case  cross-desensitization  between  MCP-3  and 
RANTES would be expected. Fig. 6 A  shows that this is 
indeed the case. In agreement with a previous study (10), 
desensitization was also observed when eosinophils were stimu- 
lated with R.ANTES followed by MIP-lcx, but not vice versa 
(Fig. 6 C), indicating that RANTES also acts on the MIP-lot 
receptor. MCP-3, however, affected only slightly the response 
of eosinophils to MlP-hx (Fig. 6/3), suggesting that it interacts 
with the MIP-lo~ receptor less effectively than RANTES. 
This may explain why RANTES prevented the response to 
MCP-3, while MCP-3 did not completdy abolish the response 
to RANTES  (Fig.  6 A).  The response to  R.ANTES was 
abrogated by combined prestimulation  with  MCP-3  and 
MIP-lo~, further indicating that RANTES acts on eosinophils 
via two distinct receptors (data not shown). 
Discussion 
Ikecent studies have indicated that  CC  chemokines are 
powerful stimuli of basophil and eosinophil lenkocytes. Three 
chemokines act on basophils: MCP-1 induces preferentially 
mediator release (4-6), while RANTES and MIP-lo~ are more 
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Figure 5.  Desensitization of basophils by sequential stimulation with 
CC cheraokin~ l~'a-2-1oaded cells (10S/ml) west sequentially stimulated 
with two CC chemokines and then with MCP-3. IL8 was u__,ed as the 
hst stimulus to show that the ceils could still respond by mobilizing 
Ca  2+ . All chemokines were used at 50 nM. [Ca2*li-dependent fluores- 
cence changes are shown. All stimulus sequences were tested at least three 
times with ceils from different uuselected donors, and identical desensiti- 
zation patterns were obtained, The only variability observed was a slight 
donor-to-donor difference in  the  maximal  [Ca2+]ilevels induced by 
different chemokines, in particular by MCP-1 (compare Hgs.  4 and 5). 
effective as chemoattractants (7-9). R.ANTES and MIP-lcx 
also activate eosinophils (10, 15). It was, therefore, of interest 
to study the effects of MCP-3, a novel CC chemokine struc- 
turally related to MCP-1 (11-13). We have found that MCP-3 
has the broadest spectrum of activity of all chemokines studied; 
it was as effective as MCP-1 as an inducer of mediator release 
in basophils, and as effective as RANTES as a stimulus of 
basophil and eosinophil migration. The fact that MCP-3 in- 
duced histamine release with similar efficacy to MCP-1 was 
expected because these chemokines share >70%  sequence 
identity. Its potent chemotactic activity, and in partio_da_r its 
action on eosinophils, were surprising, however, since the 
sequences of MCP-3 and RANTES are only distantly rehted 
(25% sequence identity). It thus appears  that sequence ho- 
mology is not necessarily predictive for the capacity of ~t 
CC chemokines to activate one or the other effector rune- 
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Figure 6.  Cross-desensitization  ofensinophils  stimulated  with MCP-3, 
RANTES, and MIP-lu. Fura-2-1oaded  calls (106/ml) swn'e stimulated 
with 50 nM chemokine,  and the [Ca  2  +  ]i-dependent  fluorescence  changes 
wes'e recorded.  An  stimulus  sequences  were  tested  four times with  cells 
from different  unsdected  donors. 
tions in basophils and eosinophils, and that activity is more 
likely to depend on discrete  sequence motifs. 
Desensitization analysis with real-time recording of a rapid 
response like the transient change in [Ca  z+ ]i is a sensitive 
way to assess receptor usage by related agonists, and the method 
of choice when only low numbers of cells are available, as 
in the present study. In such experiments evidence was ob- 
tained for the existence of distinct receptors for MCP-1 and 
RANTES on basophils (9, 10), and the present results sug- 
gest that MCP-3 not only shares the biological activities of 
two rehted chemokines, but also interacts with their receptors. 
Stimulation with MCP-3 abrogated responsiveness to MCP-1 
and RANTES. To prevent the response to MCP-3, however, 
prestimulation with both MCP-1 and RANTES was required. 
In eosinophils (which do not respond to MCP-1 and do not 
appear to express MCP-1 receptors) by contrast, RANTES 
alone was  sufficient  to fully desensitize  the cells towards 
MCP-3. 
In addition to the two receptors that are shown here to 
mediate the effects of MCP-3, our previous studies (9,  10) 
had suggested the existence of a third CC chemokine  receptor 
in basophils and ensinophils with a high affinity for MIP-lot 
and a somewhat lower affinity for RANTES. MCP-3 was 
less effident than RANTES in desensitizing the cells toward 
MIP-lc~, suggesting that RANTES is a better ligand. This 
MIP-lo~ receptor may correspond to a recently cloned CC 
chemokine receptor (16, 17) that binds MIP-lc~ with high 
affinity and also interacts with RANTES. A MIP-lc~ receptor 
is also present in human neutrophils, where MIP-lo~ and to 
a  lesser  extent  R.ANTES  were  shown  to  elicit  [Ca2+]i 
changes, but no chemotaxis or exocytosis (17, 18). We have 
found that MCP-3 induces similar [CaZ+]i changes, but no 
functional responses in neutrophils, and that these changes 
are  prevented by  prestimulation with  MIP-lob  (data  not 
shown). On the other hand, in the present study, the re- 
sponses ofbasophils to MCP-1 and MCP-3, and of eosinophils 
to RANTES and MCP-3 were not affected by prestimula- 
tion with MIP-lol, suggesting that the recently cloned receptor 
for MIP-lo~ mediates other functions. 
Our  results  suggest  the  existence  of three  chemokine 
receptors:  (a) a MCP-1 receptor expressed on basophils but 
not eosinophils that is activated by MCP-1 and MCP-3, and 
mediates predominantly mediator release; (b)  a RANTES 
receptor in basophils  and eosinophils that is activated  by 
RANTES and MCP-3, and mediates mainly chemotaxis; and 
(c) a MIP-lo~ receptor in basophils, eosinophils, and neutro- 
phils that is activated  by MIP-lc~,  R.ANTES,  and, more 
weakly, by MCP-3. The function of the MIP-lcr  receptor 
is still unclear. These conclusions are so far largely based on 
functional assays and desensitization studies,  and other in- 
terpretations are also possible. Heterologous desensitization 
of caldum transients induced by CSa and FMLP has been 
reported, particularly when the time interval between the 
two agonists is 5 min or more, and when the concentration 
of the second stimulus is suboptimal (19). We,  therefore, 
cannot exclude the presence of additional rccepto~ (e.g., MCP- 
3-specific receptors) that cross-deactivate other CC chemokine 
receptors, although we observed virtually no cross-desensitiza- 
tion of calcium transients in different grannlocyte types se- 
quentially stimulated with a large number of different agonists 
(CC chemokines, IL-8, C5a, C3a, FMLP), provided that they 
are used at high (50-100 riM) concentrations within short 
(60-90 s) time intervals  (3, 6, 9,  10; and our unpublished 
observations). Lack of desensitization between two chemoat- 
tractants, however, strongly indicates activation through dis- 
tinct receptors since we always observe full desensitization 
upon sequential exposure to the same agonist, although one 
cannot definitely exclude the possibility that a receptor oc- 
cupied by one agonist can still be activated with another dis- 
tinct ligand. Nevertheless, deactivation studies as performed 
here, particularly when combined with functional studies, 
appeared  to be surprisingly predictive for the ligand sdec- 
tivities of subsequently cloned chemoattractant receptors. For 
example, the recently cloned MIP-lol receptor is also acti- 
vated by RANTES (16, 17) as suggested in our p~ous studies 
(9, 10), despite the fact that MIP-lo~ binding is displaced by 
RANTES no more effldently than by other CC chemokines 
such as MCP-1 (16). Thus, deactivation of calcium transients 
can even give information that is not obtainable with studies 
of equilibrium binding at 4~  We therefore believe that the 
model proposed above provides a reasonable and likely expla- 
nation of our observations,  and gives a minimal estimate of 
different CC chemokine receptors present on basophils and 
eosinophils.  However,  additional  information  on  ligand 
binding and cell activation is certainly needed using cells that 
express single CC chemokine receptors isolated by cloning. 
Owing to their effects on mononuclear cells, basophils, 
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potential mediators of effector cell recruitment  and activa- 
tion in different types of chronic inflammation.  Their actual 
involvement in the pathogenesis of such conditions will de- 
pend, in addition, on their expression in the affected tissues. 
In this regard, it is interesting that a novel murine chemokine 
with homology to MCP proteins, which was termed MARC, 
is expressed preferentially by murine mast cells and mast cell 
lines (20). The 3' noncoding region of the MARC and human 
MCP-3  cDNAs  are  highly  homologous,  suggesting  that 
MARC may be the routine analogue of human MCP-3 (12). 
MCP-3 may, therefore, play a major role in the pathogenesis 
of hypersensitivity diseases  such as asthma and parasitic in- 
festations. 
MCP-1  and KANTES are CC chemokines with dearly 
distinct profiles of activity. The present results underline the 
potential importance of MCP-3 as an activator and an attrac- 
tant  of inflammatory  cells  since  it  combines,  at  least  on 
basophils and eosinophils, the biological activities of MCP-1 
and KANTES. 
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